Endothelium-independent relaxation and hyperpolarization to C-type natriuretic peptide in porcine coronary arteries

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 3, 1998, Pages 377-383

  Barton, Matthias ^a   Bény, Jean Louis ^c   D'Uscio, Livius V ^a   Wyss, Tobias ^a   Noll, Georg ^a   Lüscher, Thomas F ^a,b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NONE

Author keywords

Bradykinin; C Type atrial natriuretic peptide; Endothelium; Endothelium derived hyperpolarizing factor; Guanylate cyclase linked ANP receptors; Nitric oxide

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ATRIAL NATRIURETIC FACTOR ANTAGONIST; ATRIAL NATRIURETIC FACTOR RECEPTOR; BRADYKININ; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; GUANYLATE CYCLASE; HS 142 1; NATRIURETIC PEPTIDE TYPE C; NITRIC OXIDE; NITROPRUSSIDE SODIUM; POTASSIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY; ENDOTHELIUM CELL; HYPERPOLARIZATION; MEMBRANE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; SWINE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0345367920     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199803000-00008     Document Type: Article

References (43)

1. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
2. Lüscher TF, Vanhoutte PM, eds. The endothelium: modulator of cardiovascular function. Boca Raton, FL: CRC Press, 1990:1-215.
3. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
4. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization - beyond nitric oxide and cyclic GMP. Circulation 1995;92: 3337-49.
5. Palmer RMJ, Moncada S. A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells. Biochem Biophys Res Commun 1989;158:384-92.
6. Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 1990;87:682-5.
7. Pohl U, Holtz J, Busse R, Bassenge E. Crucial role of endothelium in the vasodilator response to increased flow in vivo. Hypertension 1986;8:37-44.
8. Mombouli JV, Vanhoutte PM. Kinins and the vascular actions of converting enzyme inhibitors. Curr Opin Nephrol Hypertens 1994; 3:481-4.
9. Richard V, Tanner FC, Tschudi M, Lüscher TF. Different activation of the endothelial L-arginine pathway by bradykinin, serotonin, and clonidine in porcine coronary arteries. Am J Physiol 1990;259: H1433-9.
10. Tschudi M, Richard V, Bühler FR, Lüscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1991;260:H13-20.
11. Paccica C, von der Weid P-Y, Bény J-L. Effect of nitro-L-arginine on endothelium-dependent hyperpolarizations and relaxations of pig coronary arteries. J Physiol (Lond) 1992;457:247-56.
12. Bény J-L, Brunet PC, Van der Bent V. Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effects. Experientia 1989;45:132-4.
13. Vanhoutte PM. Vascular physiology: the end of the quest? [News]. Nature 1987;327:459-60.
14. 9-bradykinin with isolated pig coronary arteries: mechanical and electrophysiological events. Regul Pept 1987;17:181-90.
15. Bény J-L, Gribi F. Dye and electrical coupling of endothelial cells in situ. Tissue Cell 1989;21:797.
16. Bolton TB, Lang RJ, Takewaki T. Mechanism of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J Physiol 1984;351:549-72.
17. Hoeffner U, Feletou M, Flavahan NA, Vanhoutte PM. Canine arteries release two different endothelium-derived relaxing factors. Am J Physiol 1989;257:H330-3.
18. Boulanger C, Schini VB, Hendrickson H, Vanhoutte PM. Chronic exposure of cultured endothelial cells to eicosapentaenoic acid potentiates the release of endothelium-derived relaxing factor(s). Br J Pharmacol 1990;99:176-80.
19. Bény J-L, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of the endothelially mediated vasodilation of pig coronary arteries. Blood Vessels 1988;25: 308-11.
20. Forstermann U, Alheid U, Frolich JC, Mulsch A. Mechanisms of action of lipoxygenase and cytochrome P-450-mono-oxygenase inhibitors in blocking endothelium-dependent vasodilatation. Br J Pharmacol 1988;93:569-78.
21. Macdonald PS, Read MA, Dusting GJ. Synergistic inhibition of platelet aggregation by endothelium-derived relaxing factor and prostacyclin. Thromb Res 1988;49:437-9.
22. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of expoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res 1996;78:415-23.
23. Suga S, Itoh H, Komatsu Y, et al. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells -evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology 1993;133:3038-41.
24. Nazario B, Hu R-M, Pedram A, Prins B, Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest 1995;95:1151-7.
25. Wei C-M, Hu S, Miller VM, Burnett JCJ. Vascular actions of C-type natriuretic peptide in isolated porcine coronary arteries and coronary vascular smooth muscle cells. Biochem Biophys Res Commun 1994;205:765-71.
26. Nakamura M, Arakawa N, Yoshida H, Makita S, Hiramori K. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation 1994;90:1210-4.
27. Stingo AS, Clavell AL, Aarhus LL, Burnett JC. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol 1992;262: H308-12.
28. Imura R, Sano T, Goto J, Yamada K, Matsuda Y. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors. Mol Pharmacol 1992;42:982-90.
29. Little TL, Xia J, Duling BR. Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall. Circ Res 1995;76:498-504.
30. Bény J-L, Connat J-L. An electron-microscopic study of smooth muscle cell dye coupling in the pig coronary arteries. Circ Res 1992;70:49-55.
31. Matsuda Y, Morishita Y. HS-142-1: a novel nonpeptide atrial natriuretic antagonist of microbial origin. Cardiovasc Drug Rev 1993;11: 45-59.
32. Pohl U, Busse R. EDRF increases cyclic GMP in platelets during passage through the coronary vascular bed. Circ Res 1989;65:1798-803.
33. Zeiher AM, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans: effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993;92:652-62.
34. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest 1993;92:2867-71.
35. Wiemer G, Scholkens BA, Becker RH, Busse R. Ramiprilat enhances endothelial autacoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension 1991;18:558-63.
36. Song J, Zawieja DC, Granger HJ, Goodman A, Davis MJ. Multiple ionic mechanisms activated by bradykinin in coronary venular endothelial cells. Endothelium 1996;4:29-40.
37. Archer SL, Huang JM, Hampl V, Nelson DP, Shultz PJ, Weir EK. Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 1994;91:7583-7.
38. Brunet PC, Bény J-L. Substance P and bradykinin hyperpolarize pig coronary artery endothelial cells in primary culture. Blood Vessels 1989;26:228-34.
39. Koller KJ, Lowe DG, Bennett GL, et al, Selective activation of the B natriuretic peptide receptor by C-type natriuretic peptide. Science 1991;252:120-3.
40. Suga S, Nakao K, Mukoyama M, et al. Characterization of natriuretic peptide receptors in cultured cells. Hypertension 1992;19:762-5.
41. Suga S, Nakao K, Hosoda K, et al. Receptor selectivity of natriuretic peptide family, atrial natriuretic peptide, brain natriuretic peptide, and C-type natriuretic peptide. Endocrinology 1992;130:229-39.
42. Ito Y, Kitamura K, Kuriyama H. Effects of acetylcholine and catecholamines on the smooth muscle cells of the porcine coronary artery. J Physiol (Lond) 1979;294:595-611.
43. Van der Bend V, Bény J-L. Mechanisms controlling caffeine-induced relaxation of coronary artery of the pig. Br J Pharmacol 1991;103:1877-82.